Envision Healthcare Receives a New Rating from Top Analyst

By Ryan Adsit

In a report released today, Frank Morgan from RBC Capital reiterated a Buy rating on Envision Healthcare (NYSE: EVHC), with a price target of $77. The company’s shares closed yesterday at $62.21.

According to TipRanks.com, Morgan is a top 100 analyst with an average return of 16.2% and a 74.0% success rate. Morgan covers the Services sector, focusing on stocks such as Fresenius Medical Care Corp, Quest Diagnostics Inc, and Team Health Holdings.

Envision Healthcare has an analyst consensus of Strong Buy, with a price target consensus of $73.33.

The company has a one year high of $81.34 and a one year low of $53.12. Currently, Envision Healthcare has an average volume of 1.6M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Envision Healthcare Corp. provides healthcare services, including physician-led services, ambulatory surgery center management, post-acute care and medical transportation. It owns and operates surgery centers and surgical hospital with medical specialties ranging from gastroenterology to ophthalmology and orthopedics.